The present invention relates to N.sup.2-heteroaryl-benzazole-2,(5 or 6)-diamine derivatives and compositions thereof as protein kinase inhibitors for the treatment of e.g. cancer.

 
Web www.patentalert.com

< Quinoline derivatives as nk-2 and nk-3 receptor antagonists

< Use of carnitines for the prevention and/or treatment of disorders caused by the andropause

> Method of ameliorating or abrogating the effects of a neurodegenerative disorder, such as amyotrophic lateral sclerosis (ALS), by using a HDAC inhibiting agent

> Methods and compositions for modulating sphingosine-1-phosphate (S1P) receptor activity

~ 00272